Combination therapy with the type II anti-CD20 antibody obinutuzumab

作者: Christian Klein , Marina Bacac , Pablo Umana , Günter Fingerle-Rowson

DOI: 10.1080/13543784.2017.1373087

关键词:

摘要: … Quantitative MRD is prognostic for progression-free and overall survival in elderly patients receiving chlorambucil alone or with obinutuzumab/rituximab: a prospective analysis of the …

参考文章(169)
Ian Flinn, Yasuhiro Oki, Manish Patel, Steven M. Horwitz, Francine M. Foss, Jennifer Sweeney, Kerstin Allen, Mark Douglas, Lori Steelman, Joi Dunbar, Howard M. Stern, Patrick Kelly, Brad Kahl, a Phase 1 Evaluation of Duvelisib (IPI-145), a PI3K-δ,γ Inhibitor, in Patients with Relapsed/Refractory iNHL Blood. ,vol. 124, pp. 802- 802 ,(2014) , 10.1182/BLOOD.V124.21.802.802
Sylvia Herter, Martina C. Birk, Christian Klein, Christian Gerdes, Pablo Umana, Marina Bacac, Glycoengineering of Therapeutic Antibodies Enhances Monocyte/Macrophage-Mediated Phagocytosis and Cytotoxicity Journal of Immunology. ,vol. 192, pp. 2252- 2260 ,(2014) , 10.4049/JIMMUNOL.1301249
Po-Lin Chiu, George M. Bou-Assaf, Ekta Seth Chhabra, Melissa G. Chambers, Robert T. Peters, John D. Kulman, Thomas Walz, Mapping the interaction between factor VIII and von Willebrand factor by electron microscopy and mass spectrometry Blood. ,vol. 126, pp. 935- 938 ,(2015) , 10.1182/BLOOD-2015-04-641688
Nika N Danial, Stanley J Korsmeyer, Cell Death: Critical Control Points Cell. ,vol. 116, pp. 205- 219 ,(2004) , 10.1016/S0092-8674(04)00046-7
Patrick R. Hagner, Hon-Wah Man, Celia Fontanillo, Maria Wang, Suzana Couto, Mike Breider, Chad Bjorklund, Courtney G. Havens, Gang Lu, Emily Rychak, Heather Raymon, Rama Krishna Narla, Leo Barnes, Gody Khambatta, Hsiling Chiu, Jolanta Kosek, Jian Kang, Michael D. Amantangelo, Michelle Waldman, Antonia Lopez-Girona, Ti Cai, Michael Pourdehnad, Matthew Trotter, Thomas O. Daniel, Peter H. Schafer, Anke Klippel, Anjan Thakurta, Rajesh Chopra, Anita K. Gandhi, CC-122, a pleiotropic pathway modifier, mimics an interferon response and has antitumor activity in DLBCL Blood. ,vol. 126, pp. 779- 789 ,(2015) , 10.1182/BLOOD-2015-02-628669
Michael Pfreundschuh, Gerhard Held, Samira Zeynalova, Carsten Zwick, Mathias Haenel, Lorenz Truemper, Martin H. Dreyling, Judith Dierlamm, Markus Loeffler, Norbert Schmitz, Niels Murawski, , Increased rituximab (R) doses and effect on risk of elderly male patients with aggressive CD20+ B-cell lymphomas: Results from the SEXIE-R-CHOP-14 trial of the DSHNHL. Journal of Clinical Oncology. ,vol. 32, pp. 8501- 8501 ,(2014) , 10.1200/JCO.2014.32.15_SUPPL.8501
Caylib A. Durand, Karsten Hartvigsen, Linda Fogelstrand, Shin Kim, Sally Iritani, Bart Vanhaesebroeck, Joseph L. Witztum, Kamal D. Puri, Michael R. Gold, Phosphoinositide 3-kinase p110 delta regulates natural antibody production, marginal zone and B-1 B cell function, and autoantibody responses. Journal of Immunology. ,vol. 183, pp. 5673- 5684 ,(2009) , 10.4049/JIMMUNOL.0900432
Na Li, Zhijian Sun, Ye Liu, Mingming Guo, Yilu Zhang, Dongping Zhou, Bo Zhang, Dan Su, Shuo Zhang, Jing Han, Yajuan Gao, Yunhang Guo, Zhiwei Wang, Min Wei, Lusong Luo, Lai Wang, Abstract 2597: BGB-3111 is a novel and highly selective Bruton's tyrosine kinase (BTK) inhibitor Cancer Research. ,vol. 75, pp. 2597- 2597 ,(2015) , 10.1158/1538-7445.AM2015-2597
John C. Byrd, Joseph M. Flynn, Thomas J. Kipps, Michael Boxer, Kathryn S. Kolibaba, David J. Carlile, Guenter Fingerle-Rowson, Nicola Tyson, Jamie Hirata, Jeff P. Sharman, Randomized phase 2 study of obinutuzumab monotherapy in symptomatic, previously untreated chronic lymphocytic leukemia. Blood. ,vol. 127, pp. 79- 86 ,(2016) , 10.1182/BLOOD-2015-03-634394
Jessica Donato, Federico Campigotto, Erik J. Uhlmann, Erika Coletti, Donna Neuberg, Griffin M. Weber, Jeffrey I. Zwicker, Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: a matched cohort study Blood. ,vol. 126, pp. 494- 499 ,(2015) , 10.1182/BLOOD-2015-02-626788